Frankfurt - Delayed Quote • EUR
Sirona Biochem Corp. (ZSB.F)
At close: 8:00 AM GMT+2
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Howard J. Verrico M.D., Ph.D. | Founder, Chairman of the Board, CEO & Secretary | 123.75k | -- | 1961 |
| Mr. Christopher D. Hopton C.G.A., CPA | CFO & Director | 101.28k | -- | 1966 |
| Dr. Géraldine Deliencourt-Godefroy Ph.D. | Chief Scientific Officer & Director | 146.19k | -- | -- |
Sirona Biochem Corp.
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.
Corporate Governance
Sirona Biochem Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
Recent Events Information Not Available
Upcoming Events
Jun 27, 2024 - Jul 01, 2024
Sirona Biochem Corp. Earnings Call